Caspian Debt to fund healthcare companies, partners Samridh
Caspian Debt has in principle committed up to Rs 35 crores to SAMRIDH’s commercial debt investment pool
Caspian Debt has in principle committed up to Rs 35 crores to SAMRIDH’s commercial debt investment pool
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Nearly 6,000 patients have been treated with the drug since 2017
Sun Pharma has committed Rs. 100 crores towards these initiatives
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection
Subscribe To Our Newsletter & Stay Updated